The Swiss pharmaceutical company Roche plans to build a new innovation center in Shanghai’s Pudong area. The center will open in 2019 and cost around RMB 863 million (USD 125.87 million), it will be Roche’s third largest strategic center (after those in Switzerland and the US).
The state-of-the-art innovation center is expected to boost the city’s top-level medical research and development capabilities by becoming a dream workplace for pharmaceutical scientists, said Shen Hong, head of medicinal chemistry and head of external innovation at Roche Innovation Center Shanghai, Roche R&D Center (China) Ltd.
The main focus of the center will be developing antibiotics, as well as medicines to treat hepatitis B, and inflammatory and autoimmune diseases.
